Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
How Has COVID-19 Shaped the Healthcare M&A Market?
Examining the healthcare M&A market in 2019 may seem like a strange endeavor since, for many of us, it feels like an entirely different era. But there’s value in analyzing how the healthcare M&A market in August 2020 differed from the one in August 2019, even if they both represent radically different times. The snapshot of the past will help us see how the market has changed, identifying new trends and creating a roadmap for future acquisitions. In August 2019, there were 149 transactions publicly announced, with $28.03 billion in disclosed spending, according to Deal Search Online. Transactions in the services sectors comprised the majority of activity in August 2019 at... Read More »
Health Care M&A Deals, September 4, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Nestle Health Science’s acquisition of Aimmune Therapeutics, Inc. for $2.6 billion. Nestle Health Science is acquiring Aimmune Therapeutics through its wholly-owned subsidiary, Societe des Produits Nestle S.A. The acquisition is an extension of Nestle Health Science’s food allergy portfolio, creating a broader spectrum of... Read More »
Health Care M&A Deals, August 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Royal Philips’ acquisition of Intact Vascular, Inc. for $360 million. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral... Read More »
Health Care M&A Deals, August 21, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Johnson & Johnson’s $6.5 billion acquisition of Momenta Pharmaceuticals, Inc., which provides an opportunity for JNJ to broaden its portfolio in immune-mediated diseases and autoantibody-driven diseases. To subscribe to our Health Care M&A deals chart and more, visit our membership... Read More »
Health Care M&A Deals, August 14, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Bayer AG’s $425 million acquisition of KaNDy Therapeutics Ltd., which will give Bayer KaNDy’s NT-814, a potentially first in class receptor antagonist which showed positive findings for the treatment of moderate to severe vasomotor symptoms due to menopause. To subscribe to our Health Care M&A deals chart and more,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
